{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:33:17Z","timestamp":1783783997374,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progestin-primed ovarian stimulation (PPOS) has emerged as an effective alternative to conventional pituitary suppression strategies in assisted reproductive technology cycles. While suppression of luteinizing hormone (LH) during PPOS is well established, the clinical relevance of dynamic LH changes during stimulation remains unclear. This study aimed to investigate whether serial LH dynamics are associated with follicular output in women with non\u2013low ovarian reserve undergoing PPOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 616 ovarian stimulation cycles performed using a PPOS protocol with recombinant follicle-stimulating hormone (rFSH) between January 2019 and January 2025. Serum LH concentrations were measured at three predefined time points: baseline (cycle day 2\u20133), mid-stimulation (day 6\u20137), and trigger day. LH dynamics were assessed using calculated changes between time points (\u0394LH1, \u0394LH2, \u0394LH3). Ovarian response was evaluated using the follicle-to-oocyte index (FOI), defined as the ratio of retrieved oocytes to antral follicle count (AFC). Patients were categorized as optimal responders (FOI \u226550%) or suboptimal responders (FOI &amp;lt;50%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 616 cycles analyzed, 549 patients (89.1%) demonstrated an optimal ovarian response, whereas 67 patients (10.9%) had a suboptimal response. Serum LH concentrations declined during ovarian stimulation in the overall cohort; however, LH levels were comparable between groups at all measured time points. Baseline LH levels were similar between optimal and suboptimal responders (7.21 \u00b1 2.62 vs 7.13 \u00b1 2.79 IU\/L, p=0.86), as were mid-stimulation LH levels (6.43 \u00b1 3.54 vs 6.43 \u00b1 4.35 IU\/L, p=0.99) and trigger-day LH levels (3.97 \u00b1 2.75 vs 3.92 \u00b1 2.41 IU\/L, p=0.88). Dynamic LH changes during stimulation did not differ significantly between groups, including \u0394LH1 (\u22120.77 \u00b1 3.01 vs \u22120.70 \u00b1 3.50 IU\/L, p=0.843), \u0394LH2 (\u22122.47 \u00b1 2.78 vs \u22122.52 \u00b1 3.13 IU\/L, p=0.890), and \u0394LH3 (\u22123.24 \u00b1 2.78 vs \u22123.21 \u00b1 2.40 IU\/L, p=0.936). In multivariable logistic regression analysis, female age (OR 0.909, 95% CI 0.853\u20130.969, p=0.004) and AFC (OR 0.916, 95% CI 0.892\u20130.941, p&amp;lt;0.001) were independently associated with ovarian response, whereas LH-related parameters were not significant predictors of follicular output.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In women with non\u2013low ovarian reserve undergoing PPOS, serum LH levels decline during stimulation, but their absolute values and dynamic changes are not associated with follicular output.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1825217","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:21:23Z","timestamp":1779164483000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Luteinizing hormone dynamics during progestin-primed ovarian stimulation do not predict follicular output in women with normo-ovarian reserve"],"prefix":"10.3389","volume":"17","author":[{"given":"Fazilet Kubra","family":"Boynukalin","sequence":"first","affiliation":[{"name":"Infertility Department, Bahceci Fulya In Vitro Fertilization Center","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Gultomruk","sequence":"additional","affiliation":[{"name":"R&D Department, Bahceci Health Group","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Sonmez","sequence":"additional","affiliation":[{"name":"R&D Department, Bahceci Health Group","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University","place":["Aarhus, Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Bahceci","sequence":"additional","affiliation":[{"name":"Infertility Department, Bahceci Fulya In Vitro Fertilization Center","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Bozdag","sequence":"additional","affiliation":[{"name":"Infertility Department, Bahceci Fulya In Vitro Fertilization Center","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.11.2333","article-title":"Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study","volume":"15","author":"Janssens","year":"2000","journal-title":"Hum Reprod"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)62161-x","article-title":"The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate\/gonadotrophin\/0.25 mg cetrorelix","volume":"6","author":"Tavaniotou","year":"2003","journal-title":"Reprod BioMed Online"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2004.01.033","article-title":"GnRH antagonists","volume":"115","author":"Coccia","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deag018","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI: an update in 2025","volume":"41","author":"Ata","year":"2026","journal-title":"Human Reproduction"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.5.1507","article-title":"Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new, more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00589","article-title":"Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its proposed marker\u2014the follicle-to-oocyte (FOI) index","volume":"9","author":"Alviggi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20250003","article-title":"Dydrogesterone is an eligible tool to suppress LH surge in assisted reproduction technology cycles","volume":"29","author":"Souza","year":"2025","journal-title":"JBRA Assist Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1295787","article-title":"Comparison of fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in progestin-primed ovarian stimulation: a propensity score\u2013matched study","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0046","article-title":"Rising follicle-stimulating hormone levels with age accelerate female reproductive failure","volume":"148","author":"McTavish","year":"2007","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(96)01006-7","article-title":"Gonadotropins and ovarian gonadotropin receptors during the perimenopausal transition period","volume":"23","author":"Vihko","year":"1996","journal-title":"Maturitas"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(84)90015-x","article-title":"Decrease in luteinizing hormone biological activity\/immunoreactivity ratio in elderly men","volume":"5","author":"Marrama","year":"1984","journal-title":"Maturitas"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq361","article-title":"Serum anti-M\u00fcllerian hormone levels are negatively related to follicular output rate (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation","volume":"26","author":"Genro","year":"2011","journal-title":"Hum Reprod"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad026","article-title":"Endocrine responses to triptorelin in healthy women, women with polycystic ovary syndrome, and women with hypothalamic amenorrhea","volume":"108","author":"Abbara","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.708704","article-title":"Comparison of dydrogesterone and medroxyprogesterone in the progestin-primed ovarian stimulation protocol for patients with poor ovarian response","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-025-03555-w","article-title":"Three different protocols for pituitary suppression: progestins (dydrogesterone or medroxyprogesterone acetate) versus GnRH antagonist\u2014balancing efficacy and cost in ovarian stimulation","volume":"42","author":"\u00d6zcan","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005354.pub2","article-title":"Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles","volume":"2011","author":"van Wely","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60559-7","article-title":"Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis","volume":"16","author":"Al-Inany","year":"2008","journal-title":"Reprod BioMed Online"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/genes14061269","article-title":"Genetic variants of gonadotropins and their receptors could influence controlled ovarian stimulation: IVF data from a prospective multicenter study","volume":"14","author":"Alviggi","year":"2023","journal-title":"Genes (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.02.010","article-title":"Oocyte in vitro maturation: physiological basis and application to clinical practice","volume":"119","author":"Gilchrist","year":"2023","journal-title":"Fertility Sterility"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1825217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:21:23Z","timestamp":1779164483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1825217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":22,"alternative-id":["10.3389\/fendo.2026.1825217"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1825217","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1825217"}}